Efficacy and Safety of Hydroxyethyl Starch 6% 130/0.4 in a Balanced Electrolyte Solution (Volulyte) During Cardiac Surgery

被引:43
|
作者
Base, Eva M. [1 ]
Standl, Thomas [2 ]
Lassnigg, Andrea [1 ]
Skhirtladze, Keso [1 ]
Jungheinrich, Cornelius [3 ]
Gayko, Daniela [2 ]
Hiesmayr, Michael [1 ]
机构
[1] Med Univ, Dept Anesthesiol & Intens Care Med, Vienna, Austria
[2] Univ Hosp Hamburg Eppendorf, Dept Anesthesiol, Hamburg, Germany
[3] Fresenius Kabi, Bad Homburg, Germany
关键词
balanced solutions; hydroxyethyl starches; cardiac surgery; LACTATED RINGERS SOLUTION; MAJOR ABDOMINAL-SURGERY; CRITICALLY-ILL PATIENTS; TISSUE OXYGEN-TENSION; ACID-BASE-BALANCE; METABOLIC-ACIDOSIS; VOLUME REPLACEMENT; SURGICAL PATIENTS; NORMAL SALINE; SEPTIC SHOCK;
D O I
10.1053/j.jvca.2010.12.005
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Objective: The infusion of large amounts of saline-based solutions may contribute to the development of hyperchloremic metabolic acidosis and the use of a balanced carrier for colloid solutions might improve postoperative acid-base status. The equivalence of 2 hydroxyethyl starch (HES) solutions and the influence on chloride levels and acid-base status by selectively changing the carrier of rapidly degradable modern 6% HES 130/0.4 were studied in cardiac surgery patients. Design: A prospective, randomized, double-blinded study. Setting: A clinical study in 2 cardiac surgery institutions. Participants: Eighty-one patients. Intervention: Patients received either 6% HES130/0.4 balanced (Volulyte; Fresenius Kabi, Bad Homburg, Germany) or 6% HES130/0.4 saline (Voluven; Fresenius Kabi, Bad Homburg, Germany) for intra- and postoperative hemodynamic stabilization. Measurements and Main Results: The therapeutic equivalence of both HES formulations regarding volume effect and superiority of the balanced electrolyte solution regarding serum chloride levels and acid-base status were measured. Similar volumes of both HES 130/0.4 balanced and HES 130/0.4 saline were administered until 6 hours after surgery, 2,391 +/- 518 mL in the HES 130/0.4 balanced group versus 2,241 +/- 512 mL in the HES 130/0.4 saline group. The 95% confidence interval for the difference between treatments (-77; 377 mL; mean, 150 mL) was contained entirely in the predefined interval (-500, 500 mL), thereby proving equivalence. The serum chloride level (mmol/L) was lower (p < 0.05 at the end of surgery), and arterial pH was higher in the balanced group at all time points except baseline, and base excess was less negative at all time points after baseline (p < 0.01). Conclusions: Volumes of HES needed for hemodynamic stabilization were equivalent between treatment groups. Significantly lower serum chloride levels in the HES balanced group reflected the lower chloride load of similar infusion volumes. The HES balanced group had significantly less acidosis. (C) 2011 Elsevier Inc. All rights reserved.
引用
收藏
页码:407 / 414
页数:8
相关论文
共 50 条
  • [1] The Effect of Intraoperative 6% Balanced Hydroxyethyl Starch (130/0.4) During Cardiac Surgery on Transfusion Requirements
    Hans, Gregory A.
    Ledoux, Didiier
    Roediger, Laurence
    Hubert, Marie Bernard
    Koch, Jean-Noel
    Senard, Marc
    JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2015, 29 (02) : 328 - 332
  • [2] Hydroxyethyl Starch 6% 130/0.4 in a Balanced Electrolyte Solution and Renal Function After Nephrectomy
    Lee, Ho-Jin
    Kwon, Yongsuk
    Bae, Jinyoung
    Yoo, Seokha
    Yoon, Hee-Chul
    Yoon, Soo-Hyuk
    Kim, Jin-Tae
    Bahk, Jae-Hyon
    Kim, Won Ho
    ANESTHESIA AND ANALGESIA, 2020, 131 (04): : 1260 - 1269
  • [3] Comparison of 6% HES 130/0.4 in a balanced electrolyte solution versus 6% HES 130/0.4 in saline solution in cardiac surgery
    E Base
    T Standl
    C Mahl
    C Jungheinrich
    Critical Care, 10 (Suppl 1):
  • [4] Hydroxyethyl starch 130/0.4: Safe in cardiac surgery?
    Davidson, Ingemar J.
    CRITICAL CARE MEDICINE, 2008, 36 (05) : 1695 - 1696
  • [5] Hydroxyethyl starch 130/0.4: Safe in cardiac surgery? Reply
    Boldt, Joachim
    CRITICAL CARE MEDICINE, 2008, 36 (05) : 1696 - 1696
  • [6] Safety of hydroxyethyl starch 130/0.4 in paediatric cardiac patients - a reply
    Oh, H. W.
    Lee, J. H.
    Kim, J. T.
    ANAESTHESIA, 2018, 73 (05) : 651 - 652
  • [7] Is hydroxyethyl starch 130/0.4 the optimal starch plasma substitute in adult cardiac surgery?
    Huet, R
    Siemons, W
    Hagenaars, A
    Von Oeveren, W
    ANESTHESIA AND ANALGESIA, 1998, 86 (04): : SCA80 - SCA80
  • [8] Assessing the renal safety of hydroxyethyl starch 130/0.4 in paediatric cardiac patients
    Xue, F. S.
    Liu, Q.
    Wen, C.
    ANAESTHESIA, 2018, 73 (05) : 650 - 651
  • [9] Efficacy and safety of 6% hydroxyethyl starch 130/0.4 (Voluven) for perioperative volume replacement in children undergoing cardiac surgery: a propensity-matched analysis
    Philippe Van der Linden
    Melanie Dumoulin
    Celine Van Lerberghe
    Cristel Sanchez Torres
    Ariane Willems
    David Faraoni
    Critical Care, 19
  • [10] Efficacy and safety of 6% hydroxyethyl starch 130/0.4 (Voluven) for perioperative volume replacement in children undergoing cardiac surgery: a propensity-matched analysis
    Van der Linden, Philippe
    Dumoulin, Melanie
    Van Lerberghe, Celine
    Torres, Cristel Sanchez
    Willems, Ariane
    Faraoni, David
    CRITICAL CARE, 2015, 19